Biotech

All Articles

Vaxcyte climbs on 'spectacular' 31-valent PCV gain versus Pfizer

.Vaxcyte revealed what analysts called "stunning" stage 1/2 records for its own 31-valent pneumococc...

Recursion's mind illness trial reveals little evidence of efficacy

.Recursion has stumbled with a very early test of its own tech-enabled method to medication revelati...

Acepodia, Pfizer click on together for chemistry-based tissue therapy

.Call it an instance of good chemistry: Acepodia, a biotech based upon Nobel Champion scientific res...

Praxis epilepsy medication decreases confiscations in phase 2 hearing

.Practice Precision Medicines has actually scored another midphase gain in epilepsy this year, along...

Three officers surrender as Dyne posts blended data for DMD candidate

.After running away a clinical hold many years back, Dyne Therapeutics has actually disclosed brand-...

Arrowhead fires off phase 3 information in unusual metabolic condition before market clash with Ionis

.Arrowhead Pharmaceuticals has actually revealed its own give ahead of a prospective showdown along ...

Pfizer, Valneva present lyme disease chance efficient for 2nd enhancer

.Pfizer and also Valneva may possess regarding two more years to hang around just before they make t...

Fierce Biotech Managing Editor Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Let's study a talk along with Ayla Ellison, Brutal Biotech Managing Editor and Michelle Benz as the...

New records demonstrate how Bayer's asundexian fell short to prevent movements

.Bayer suspended the phase 3 trial for its own element XIa inhibitor asundexian behind time in 2015 ...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS tests

.Sanofi is still set on taking its own a number of sclerosis (MS) med tolebrutinib to the FDA, manag...